GWM
VATE icon

Geneos Wealth Management’s INNOVATE Corp VATE Stock Holding History

Geneos Wealth Management’s Portfolio VATE Stock Details VATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-196
Closed -$7K – 1855
2016
Q1 		$7K Buy
+196
New +$7.52K ﹤0.01% 1423

Other funds holding VATE

JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
MIM
Mittleman Investment Management Melville, New York $17.4M AUM 36.11% 1-Year Est. Return
WIM
Wingspan Investment Management New York $215M AUM 30.25% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
SPH
Steel Partners Holdings New York $96.4M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geneos Wealth Management's VATE Position: Q2 2016 in Review

Geneos Wealth Management sold out of INNOVATE Corp (VATE) in Q2 2016, closing a stake of 196 shares — an estimated $7K sold.

Geneos Wealth Management first reported a position in VATE in Q1 2016 and held it in 1 quarter. The position peaked at $7K in Q1 2016. 66 funds tracked by Wall St. Rank hold VATE as of Q2 2016.

  • Geneos Wealth Management reported no remaining INNOVATE Corp position as of Q2 2016 after selling out during the quarter.
  • Geneos Wealth Management sold 196 INNOVATE Corp shares in Q2 2016, an estimated $7K.
  • Geneos Wealth Management first reported a position in INNOVATE Corp in Q1 2016 and held it in 1 quarter.
  • Geneos Wealth Management's INNOVATE Corp position peaked at $7K in Q1 2016.
  • 66 funds tracked by Wall St. Rank held INNOVATE Corp as of Q2 2016.

Based on Geneos Wealth Management's 13F filing for Q2 2016, filed 7 Sep 2021.